›› 2014, Vol. 29 ›› Issue (11): 1198-1202.DOI: 10.3969/j.issn.1673-8640.2014.11.028
• Orignal Article • Previous Articles
Received:
2014-07-29
Online:
2014-11-01
Published:
2014-11-28
Contact:
蔡会欣,联系电话:0312-5976674。
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.11.028
[1] Hermann LK,Weingart SD,Yoon YM,et al.Comparison of frequency of inducible myocardial ischemia in patients presenting to emergency department with typical versus atypical or nonanginal chest pain [J]. Am J Cardiol,2010,105(11):1561-1564. [2] 何 星,韦腾飞,沈 茜.高敏肌钙蛋白在急性冠状动脉综合征中的临床应用价值[J].检验医学,2013,28(12):1152-1156. [3] 郭彩霞,杜凤和,陈瑞芬,等.颅脑损伤后心肌病变的实验研究[J].中国急救医学,2003,23(4):211-213. [4] 王苏燕,杨 军,邓 彪,等.冠心病患者外周血NT-proBNP水平与GRACE评分的相关性分析[J].山东医药,2013,53(18):22-23. [5] Worster A,Devereaux PJ,Heels-Ansdell D,et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome[J]. CMAJ,2005,172(13):1685-1690. [6] Lippi G,Montagnana M,Salvagno GL,et al.Potential value for new diagnostic markers in the early recognition of acute coronary syndromes[J]. CJEM,2006,8(1):27-31. [7] 吴卫华,易建华. 冠心病生化标志物多项联合检测的互补效应探讨[J]. 检验医学,2012,27(5):361-363. [8] 尹栩芳,沈 霞,刘 峰,等. 血清缺血修饰白蛋白测定在心肌缺血早期的临床应用价值[J]. 检验医学,2009,24(10):742-745. [9] 游洁芸,杨承健,金 艳,等. 缺血修饰白蛋白在急性冠状动脉综合征诊断中的应用价值[J]. 检验医学,2010,25(4):338-339. [10] 崔丽艳,张 捷,胡晓舟. 心型脂肪酸结合蛋白和缺血修饰白蛋白在肌钙蛋白T未增高的急性冠状动脉综合征患者中联合检测的价值[J]. 检验医学,2010,25(7):539-542. [11] Granger CB,Goldberg RJ,Dabbous O,et al.Predictors of hospital mortality in the global registry of acute coronary events[J].Arch Intern Med,2003,163(19):2345-2353. [12] Raposeiras-Roubín S,Aguiar-Souto P,Barreiro-Pardal C,et al.GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function[J].Angiology,2013,64 (1):31-39. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||